Please login to the form below

Not currently logged in
Email:
Password:

Calliditas

This page shows the latest Calliditas news and features for those working in and with pharma, biotech and healthcare.

Calliditas bets on PBC drug in Genkyotex buyout

Calliditas bets on PBC drug in Genkyotex buyout

Calliditas will acquire 62.7% of company for an initial 20.3m. Calliditas is set to acquire a controlling interest in French biotech Genkyotex, gaining access to its lead primary biliary ... Calliditas will acquire 62.7% of Genkyotex in an initial

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics. ... He said: “I am excited to take on this role at Calliditas.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....